Commentary: Illegal Immigration’s Impact on Public Health

Illegal Immigrants

Successful public health campaigns and medical advances have enabled the United States to conquer a range of disfiguring and damaging diseases. Polio, which paralyzed thousands of Americans annually, was wiped out by widespread vaccinations. In 1999 the nation’s last hospital for lepers closed its doors in Louisiana. A global campaign eradicated smallpox, while lethal tuberculosis, the “consumption” that stalked characters in decades of literature, seemed beaten by antibiotics. Measles outbreaks still occur from time to time, but they are small, local, and easily contained.

Recently, however, some of these forgotten but still formidable infectious diseases have begun to reappear in the U.S. For two years running, polio has been detected in some New York water samples, and this fall, leprosy re-emerged in Florida, where cases of malaria have also been recorded.

Read More

Afghan Refugees Bringing Numerous Diseases to U.S., Including Measles, Malaria, and Tuberculosis

The tens of thousands of Afghan refugees being imported into the United States by the Biden Administration are carrying numerous dangerous diseases in addition to the Chinese coronavirus, including malaria, measles, and tuberculosis, as reported by Breitbart.

The Centers for Disease Control (CDC) admitted to the influx of diseases through the Afghan arrivals in a statement on Monday, declaring that all of the refugees will be required to take the measles vaccine; however, there are still no measures in place to require them to receive a coronavirus vaccine.

According to the CDC press release, they had been “notified by public health departments of 16 measles cases among the evacuees.” Subsequently, they ordered that “evacuees who are in the United States are required to be vaccinated with MMR and complete a 21-day quarantine from the time of vaccination at U.S. ‘Safe Haven’ designated locations.”

Read More

Money and Politics Behind Anti-Hydroxychloroquine Bias, New Report Suggests

Remdesivir, an antiviral medication that was developed by the biopharmaceutical company Gilead Sciences, has been widely touted as the most promising drug to treat COVID-19, even though – so far – the new and expensive drug does not seem to be terribly effective at fighting the disease.

The anti-malaria drug hydroxychloroquine, on the other hand, is cheap, has been used safely for decades, and has shown great promise as a weapon in the fight against the coronavirus – yet after President Trump mentioned it as a promising potential treatment for the disease, the media immediately blasted him for touting an “unproven” and potentially unsafe drug.

Read More